You are here

biomarkers

ALS researchers at Harvard uncover new biomarker and drug target

ALS researchers at Harvard uncover new biomarker and drug target

Fierce Biotech

Lou Gehrig's disease

Flag link:

Phoenix, Roche partner to develop TNBC biomarker

Phoenix, Roche partner to develop TNBC biomarker

BioCentury

Phoenix Molecular Designs

molecular diagnostics

triple negative breast cancer

Flag link:

Data Scientist Explains How AI's Seductive Power Can Mislead Biomarker Researchers

Data Scientist Explains How AI's Seductive Power Can Mislead Biomarker Researchers

Forbes

artificial intelligence

Flag link:

Merck taps Roche for Keytruda companion diagnostic

Merck taps Roche for Keytruda companion diagnostic

Medtech Dive

companion diagnostics

Flag link:

Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk

Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk

CP Wire

prostate cancer

Flag link:

FDA grants first qualification of a clinical safety biomarker

FDA grants first qualification of a clinical safety biomarker

BioCentury

acute kidney injury

Flag link:

[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®

[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®

CP Wire

Flag link:

[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®

Flag link:

Diagnosing Depression By Blood Biomarkers: A Viable Approach?

Diagnosing Depression By Blood Biomarkers: A Viable Approach?

Forbes

Flag link:

Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs

Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs

Fierce Biotech

Flag link:

ASCO: Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it?

ASCO: Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it?

Fierce Pharma

Bristol-Myers Squibb

Flag link:

Preliminary Study Finds Potential Biomarker of Subconcussive Head Trauma

Preliminary Study Finds Potential Biomarker of Subconcussive Head Trauma

CP Wire

Flag link:

Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection

Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection

CP Wire

pancreatic cancer

Flag link:

CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease

CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease

CP Wire

inflammatory bowel disease

Flag link:

After yet another PhIII Alzheimer’s failure, experts try to map a path out of the wrecking field

After yet another PhIII Alzheimer’s failure, experts try to map a path out of the wrecking field

Endpoints

Alzheimer's disease

Flag link:

First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)

First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)

CP Wire

Denovo Therapeutics

Flag link:

This biotech aims to transform the diagnosis of mental illness. Michael Phelps backs it. Can it really work?

This biotech aims to transform the diagnosis of mental illness. Michael Phelps backs it. Can it really work?

Stat

Flag link:

FDA approves diagnostic that simultaneously screens for multiple cancer biomarkers

FDA approves diagnostic that simultaneously screens for multiple cancer biomarkers

Drug Delivery Business News

non-small cell lung cancer

Oncomine Dx Target Test

Flag link:

An Unprecedented FDA Approval Bodes Well for this Drug Stock

An Unprecedented FDA Approval Bodes Well for this Drug Stock

Motley Fool

Flag link:

Loxo takes center stage at ASCO with its groundbreaking shot at a biomarker-based cancer drug approval

Loxo takes center stage at ASCO with its groundbreaking shot at a biomarker-based cancer drug approval

Endpoints

Flag link:

Pages